Andere talen Reneo Pharmaceuticals, Inc.

Aandelen

RPHM

US75974E1038

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,67 ^USD	+1,21%		-4,02%	+4,38%

28/03	Reneo Pharmaceuticals, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	RENEO PHARMACEUTICALS, INC. : Ladenburg Thalmann herziet opinie en gaat over naar Neutraal	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	28/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Wall Street ouvre stable en l'absence de nouveaux catalyseurs	27/12
Concentra Biosciences, LLC submitted a non-binding proposal to acquire Reneo Pharmaceuticals, Inc. for $60 million.	26/12
North American Morning Briefing : Stock Futures -2-	18/12
Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) added to NASDAQ Biotechnology Index	18/12
Sector Update: Health Care Stocks Slipping Late Afternoon	14/12
Top Midday Decliners	14/12
Sector Update: Health Care Stocks Ease Thursday Afternoon	14/12
Reneo Pharmaceuticals Says Pivotal Study of Mavodelpar Fails to Meet Primary, Secondary Endpoints; Shares Plunge	14/12
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14/12
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14/12
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results	13/11
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02/11
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02/11
Women in Stem with Ashley Hall	31-10-23
Reneo Pharmaceuticals, Inc. announces an Equity Buyback for 576,443 shares, for $4.4 million.	30-10-23
Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.	30-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Reneo Pharmaceuticals, Inc.

Aandelen

RPHM

US75974E1038

Andere talen

Filters